Share ownership Neuronetics, Inc.

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
1.520 ^USD	+10.95%		+12.59%	-5.59%

Dec. 10	Neuronetics, Inc., Q3 2025 Earnings Call, Nov 04, 2025
Nov. 04	Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Share class: Neuronetics, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	55,652,475	26,983,307 ( 48.49 %)	0	48.49 %

Major shareholders: Neuronetics, Inc.

Name	Equities	%	Valuation
Madryn Asset Management LP 31.36 %	20,737,061	31.36 %	31 M $
Jorey Chernett 6.659 %	4,403,498	6.659 %	7 M $
Vanguard Fiduciary Trust Co. 4.283 %	2,832,118	4.283 %	4 M $
BlackRock Advisors LLC 3.327 %	2,199,930	3.327 %	3 M $
UBS Financial Services, Inc. 3.266 %	2,159,905	3.266 %	3 M $
Sasha Cucuz 3.071 %	2,030,924	3.071 %	3 M $
Balyasny Asset Management LP 2.755 %	1,821,649	2.755 %	3 M $
Wexford Capital LP 1.78 %	1,177,225	1.78 %	2 M $
Masters Capital Management LLC 1.512 %	1,000,000	1.512 %	1 M $
Keith Sullivan 1.418 %	937,959	1.418 %	1 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	60.97%
Individuals	14.24%
Other	1.67%
State Street Corp.	0.89%
Unknown	22.23%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	60.98%
Individuals	14.24%
United Kingdom	1.82%
Canada	0.55%
Luxembourg	0.12%
Cayman Islands	0.04%
Hong Kong	0.02%

Based on 1000 largest holdings

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Employees

716

Sector

Advanced Medical Equipment & Technology

Calendar

Mar. 09 - Q4 2025 Earnings Release (Projected)

More about the company